Investment Banking

POW.RE to Acquire Block Green, Expanding Bitcoin Financial Services Infrastructure

POW.RE to Acquire Block Green, Expanding Bitcoin Financial Services Infrastructure

Canadian Bitcoin miner POW.RE plans to acquire Swiss financial services firm Block Green, creating a comprehensive platform for Bitcoin mining financial solutions with enhanced market access and innovative products.

May 14, 2025
FAVO Capital Converts Super Voting Shares, Signals Nasdaq Uplisting Intentions

FAVO Capital Converts Super Voting Shares, Signals Nasdaq Uplisting Intentions

FAVO Capital Inc. has voluntarily converted its Super Voting Series C Preferred Shares to common stock, streamlining its capital structure and preparing for a potential Nasdaq listing, demonstrating a commitment to transparent corporate governance.

May 13, 2025
Aristocrat Group Corporation Takes First Steps Toward Public Market Re-Entry

Aristocrat Group Corporation Takes First Steps Toward Public Market Re-Entry

Aristocrat Group Corporation initiates SR-211 filing process to improve stock market visibility and enable public trading, signaling a strategic move to enhance investor access and corporate transparency.

May 12, 2025
Aegis Capital Leads Super League Enterprise Public Offering, Raises Nearly $870,000

Aegis Capital Leads Super League Enterprise Public Offering, Raises Nearly $870,000

Aegis Capital Corp. has completed an underwritten public offering for Super League Enterprise, raising approximately $869,999 through the sale of 5,117,647 shares. The funding will support the company's corporate objectives and debt management strategies.

May 12, 2025
Quantum BioPharma Files $700M Market Manipulation Lawsuit Against Financial Institutions

Quantum BioPharma Files $700M Market Manipulation Lawsuit Against Financial Institutions

Quantum BioPharma has initiated a significant legal action against multiple financial institutions, alleging securities law violations through market manipulation tactics between 2020 and 2024, seeking substantial damages.

May 5, 2025
Brazil Potash Bolsters Advisory Board with Seasoned Agriculture Finance Expert

Brazil Potash Bolsters Advisory Board with Seasoned Agriculture Finance Expert

Brazil Potash strengthens its strategic leadership by appointing Marcelo Lessa, a veteran with extensive international finance experience, to support its critical Autazes Project development and potash production strategy.

April 28, 2025
Lexaria Bioscience Secures $2 Million in Registered Direct Offering

Lexaria Bioscience Secures $2 Million in Registered Direct Offering

Lexaria Bioscience has entered into a definitive agreement to raise $2 million through a registered direct offering of common stock, providing capital for working capital and general corporate purposes.

April 25, 2025
Economic Uncertainty Stalls Investment Banking Recovery in Early 2025

Economic Uncertainty Stalls Investment Banking Recovery in Early 2025

Major U.S. banks report modest investment banking revenues in Q1 2025, reflecting ongoing economic challenges and market volatility that are delaying the sector's anticipated revival.

April 25, 2025
Investment Banking Revival Stalls Amid Economic Uncertainty

Investment Banking Revival Stalls Amid Economic Uncertainty

Major U.S. banks experienced lower-than-expected investment banking revenues in the first quarter of 2025, reflecting broader economic challenges and market volatility that are delaying sector recovery.

April 24, 2025
ROTH Capital Partners Celebrates 25 Years of Community Impact at Annual Conference

ROTH Capital Partners Celebrates 25 Years of Community Impact at Annual Conference

The 37th Annual ROTH Conference in Dana Point, California, marked a significant milestone in the firm's history, highlighting its deep-rooted community connections and commitment to fostering meaningful relationships over the past quarter-century.

April 17, 2025
Stonegate Initiates Coverage on Alpha Cognition, Projects Strong Growth for New Alzheimer's Drug

Stonegate Initiates Coverage on Alpha Cognition, Projects Strong Growth for New Alzheimer's Drug

Alpha Cognition's newly approved Alzheimer's drug ZUNVEYL is positioned to address a significant market gap with a potentially safer treatment option, as Stonegate Capital Partners initiates coverage with a valuation range of $27.62 to $38.44 per share.

February 4, 2025
PreviousPage 6 of 6Next